BHVN
Biohaven Ltd.
Company overview
- Market capitalization
- $2.00B
- Employees
- 274
- Latest publication
- 2026-09-29
About Biohaven Ltd.
Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 2 clinical trial for treating IgA nephropathy; BHV-1600, which is in Phase 1 clinical trial for the treatment of peripartum cardiomyopathy; BHV-8000 that is in Phase 3 clinical trial for treating Parkinson's disease; Opakalim, which is in Phase 3 clinical trial for the treatment of focal epilepsy; BHV-2100 that is in Phase 2 clinical trial for the treatment of pain disorders; and BHV-2000, which is in Phase 2 clinical trial for treating obesity. The company is also developing BHV-1510 that is in Phase 2 clinical trial for the treatment of advanced or metastatic epithelial tumors; and BHV-1530, which is in Phase 2 clinical trial for treating urothelial cancer and other tumors. In addition, its preclinical product pipeline includes BHV-1310 for treating myasthenia gravis; BHV-1320 for treating immune mediated-diseases; BHV-1450 for treating Pemphigus, MuSK MG, and LGI-1 Encephalitis; BHV-1420 for treating membranous nephropathy; BHV-1440 for treating Graves' disease and TED; BHV-6500 for treating type 1 diabetes; BHV-1490 for treating IgM neuropathy and Waldenstrom's; BHV-8100 for treating neurodegenerative diseases; and BHV-1955 for treating tinnitus. The company was formerly known as Biohaven Research Ltd. and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 3,836,000USD | 0USD | 0USD |
| Research Development | 103,827,000USD | 121,945,000USD | 141,169,000USD | 184,367,000USD | 187,584,000USD | 167,473,000USD | 157,607,000USD | 314,819,000USD |
| Selling General Administrative | 26,601,000USD | 20,789,000USD | 28,213,000USD | 27,334,000USD | 33,977,000USD | 22,458,000USD | 20,561,000USD | 18,953,000USD |
| Total Operating Expenses | 130,428,000USD | 141,774,000USD | 168,277,000USD | 211,701,000USD | 221,561,000USD | 189,931,000USD | 178,168,000USD | 333,772,000USD |
| Operating Income | -130,428,000USD | -142,734,000USD | -169,382,000USD | -211,701,000USD | -221,561,000USD | -189,931,000USD | -178,168,000USD | -333,772,000USD |
| Income Before Tax | -130,260,000USD | -145,204,000USD | -173,222,000USD | -197,886,000USD | -221,068,000USD | -186,795,000USD | -160,363,000USD | -319,594,000USD |
| Income Tax Expense | 272,000USD | 351,000USD | 221,000USD | 261,000USD | 609,000USD | 48,000USD | -59,000USD | 177,000USD |
| Tax Provision | 272,000USD | 351,000USD | 221,000USD | 261,000USD | 609,000USD | 48,000USD | -59,000USD | 177,000USD |
| Net Income | -130,532,000USD | -145,555,000USD | -173,443,000USD | -198,147,000USD | -221,677,000USD | -186,843,000USD | -160,304,000USD | -319,771,000USD |
| Net Income From Continuing Ops | -130,532,000USD | -145,555,000USD | -173,443,000USD | -198,147,000USD | -221,677,000USD | -186,843,000USD | -160,304,000USD | -319,771,000USD |
| Ebit | -130,428,000USD | -145,204,000USD | -173,222,000USD | -211,701,000USD | -221,561,000USD | -189,931,000USD | -178,168,000USD | -333,772,000USD |
| Ebitda | -128,062,000USD | -142,631,000USD | -172,117,000USD | -209,723,000USD | -219,315,000USD | -187,470,000USD | -176,174,000USD | -331,818,000USD |
| Depreciation And Amortization | 2,366,000USD | 2,573,000USD | 1,105,000USD | 1,978,000USD | 2,246,000USD | 2,461,000USD | 1,994,000USD | 1,954,000USD |
| Reconciled Depreciation | 2,366,000USD | 2,573,000USD | 3,125,000USD | 1,978,000USD | 2,246,000USD | 2,461,000USD | 1,994,000USD | 1,954,000USD |
| Total Other Income Expense Net | 168,000USD | -2,470,000USD | -3,840,000USD | 13,815,000USD | 493,000USD | 3,136,000USD | 17,805,000USD | 14,178,000USD |
| Cost Of Revenue | — | 960,000USD | 1,105,000USD | — | 1,014,999USD | 1,918,000USD | 1,000,000USD | 977,000USD |
| Gross Profit | — | -960,000USD | -1,105,000USD | — | -1,014,999USD | 1,918,000USD | -1,000,000USD | -977,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 977,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 462,509,000USD | 0USD | — | — |
| Cost Of Revenue | 4,139,999USD | 3,923,000USD | 3,369,000USD | 1,386,000USD | 1,393,000USD | 72,000USD | — | — |
| Gross Profit | -4,139,999USD | -3,923,000USD | -3,369,000USD | -1,386,000USD | 370,845,000USD | -72,000USD | — | — |
| Research Development | 635,065,000USD | 795,871,000USD | 373,281,000USD | 437,072,000USD | 181,486,000USD | 98,460,000USD | 344,673,000USD | — |
| Selling General Administrative | 106,173,000USD | 89,240,000USD | 62,770,000USD | 130,860,000USD | 37,414,000USD | 16,046,000USD | 134,449,000USD | — |
| Total Operating Expenses | 741,238,000USD | 885,111,000USD | 436,051,000USD | 567,932,000USD | 218,900,000USD | 114,506,000USD | 479,122,000USD | — |
| Operating Income | -745,378,000USD | -885,111,000USD | -436,051,000USD | -567,932,000USD | -218,900,000USD | -114,506,000USD | -479,122,000USD | — |
| Income Before Tax | -737,380,000USD | -845,687,000USD | -409,551,000USD | -569,841,000USD | -212,430,000USD | -118,668,000USD | -528,386,000USD | — |
| Income Tax Expense | 1,442,000USD | 735,000USD | -1,383,000USD | 438,000USD | 1,366,000USD | -134,000USD | 419,000USD | — |
| Tax Provision | 1,442,000USD | 735,000USD | -1,383,000USD | 438,000USD | 1,366,000USD | 0USD | — | — |
| Net Income | -738,822,000USD | -846,422,000USD | -408,168,000USD | -570,279,000USD | -213,796,000USD | -118,668,000USD | -528,805,000USD | — |
| Net Income From Continuing Ops | -738,822,000USD | -846,422,000USD | -408,168,000USD | -570,279,000USD | -848,396,000USD | -118,668,000USD | — | — |
| Ebit | -737,380,000USD | -885,111,000USD | -436,051,000USD | -567,932,000USD | -218,900,000USD | -114,506,000USD | -479,122,000USD | — |
| Ebitda | -727,458,000USD | -877,256,000USD | -429,139,000USD | -566,546,000USD | -217,507,000USD | -114,434,000USD | -479,122,000USD | — |
| Depreciation And Amortization | 9,922,000USD | 7,855,000USD | 6,912,000USD | 1,386,000USD | 1,393,000USD | 72,000USD | 171,860USD | 52,516USD |
| Reconciled Depreciation | 9,922,000USD | 7,855,000USD | 6,912,000USD | 1,386,000USD | 1,393,000USD | 72,000USD | — | — |
| Total Other Income Expense Net | 7,998,000USD | 39,424,000USD | 26,500,000USD | -1,909,000USD | 6,470,000USD | -4,162,000USD | -49,264,000USD | — |
| Interest Expense | — | — | — | 1,386,000USD | 41,551,000USD | — | 12,711,000USD | — |
| Net Income Applicable To Common Shares | — | — | — | -570,279,000USD | -846,586,000USD | -118,668,000USD | — | — |
| Non Operating Income Net Other | — | — | — | — | -65,435,000USD | — | — | — |
| Minority Interest | — | — | — | — | -1,810,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 466,406,000USD | 451,447,000USD | 409,123,000USD | 550,415,000USD | 458,946,000USD | 615,107,000USD | 510,523,000USD | 582,641,000USD |
| Intangible Assets | 18,400,000USD | 18,400,000USD | 18,400,000USD | 18,400,000USD | 18,400,000USD | 18,400,000USD | 18,400,000USD | 18,400,000USD |
| Other Current Assets | 37,832,000USD | 49,192,000USD | 63,398,000USD | 69,847,000USD | 60,008,000USD | 49,884,000USD | 56,366,000USD | 66,798,000USD |
| Total Liab | 336,906,000USD | 399,375,000USD | 426,283,000USD | 415,828,000USD | 199,451,000USD | 191,671,000USD | 194,517,000USD | 198,901,000USD |
| Total Stockholder Equity | 129,500,000USD | 52,072,000USD | -17,160,000USD | 134,587,000USD | 259,495,000USD | 423,436,000USD | 316,006,000USD | 383,740,000USD |
| Other Current Liab | 41,653,000USD | 104,291,000USD | 90,020,000USD | 100,000,000USD | 140,184,000USD | 132,395,000USD | 128,874,000USD | 135,398,000USD |
| Common Stock | 2,132,908,000USD | 1,934,276,000USD | 1,743,740,000USD | 1,743,109,000USD | 1,689,346,000USD | 1,656,702,000USD | 1,381,699,000USD | 1,298,553,000USD |
| Capital Stock | 2,132,908,000USD | 1,934,276,000USD | 1,743,740,000USD | 1,743,109,000USD | 1,689,346,000USD | 1,656,702,000USD | 1,381,699,000USD | 1,298,553,000USD |
| Retained Earnings | -2,215,068,000USD | -2,084,536,000USD | -1,938,981,000USD | -1,765,538,000USD | -1,567,391,000USD | -1,345,714,000USD | -1,158,871,000USD | -998,567,000USD |
| Good Will | 1,390,000USD | 1,390,000USD | 1,390,000USD | 1,390,000USD | 1,390,000USD | 1,390,000USD | 1,390,000USD | 1,390,000USD |
| Cash | 273,074,000USD | 229,957,000USD | 184,847,000USD | 165,797,000USD | 98,417,000USD | 99,134,000USD | 84,390,000USD | 239,147,000USD |
| Cash And Short Term Investments | 347,817,000USD | 319,137,000USD | 260,217,000USD | 404,980,000USD | 322,749,000USD | 485,991,000USD | 378,816,000USD | 436,948,000USD |
| Total Current Assets | 385,649,000USD | 368,329,000USD | 323,615,000USD | 474,827,000USD | 382,757,000USD | 538,472,000USD | 440,500,000USD | 511,268,000USD |
| Total Current Liabilities | 52,075,000USD | 115,934,000USD | 113,023,000USD | 124,324,000USD | 164,034,000USD | 154,226,000USD | 152,294,000USD | 156,207,000USD |
| Net Debt | 7,201,000USD | 48,901,000USD | 129,329,000USD | 125,766,000USD | -62,905,000USD | -62,550,000USD | -55,402,000USD | -209,404,000USD |
| Short Long Term Debt Total | 280,275,000USD | 278,858,000USD | 314,176,000USD | 291,563,000USD | 35,512,000USD | 36,584,000USD | 28,988,000USD | 29,743,000USD |
| Long Term Debt | 241,912,000USD | 238,900,000USD | 268,270,000USD | 257,070,000USD | — | — | — | — |
| Short Term Investments | 74,743,000USD | 89,180,000USD | 75,370,000USD | 239,183,000USD | 224,332,000USD | 386,857,000USD | 294,426,000USD | 197,801,000USD |
| Accounts Payable | 10,422,000USD | 11,643,000USD | 17,491,000USD | 19,628,000USD | 19,142,000USD | 18,029,000USD | 19,744,000USD | 17,259,000USD |
| Property Plant Equipment Net | 15,256,000USD | 15,964,000USD | 62,722,000USD | 52,835,000USD | 53,222,000USD | 53,711,000USD | 47,184,000USD | 48,568,000USD |
| Property Plant Equipment Gross | 75,490,000USD | 77,148,000USD | 78,108,000USD | 67,116,000USD | 66,443,000USD | 65,917,000USD | 58,385,000USD | 58,769,000USD |
| Accumulated Other Comprehensive Income | 8,302,000USD | 8,348,000USD | 36,000USD | -3,000USD | 73,000USD | 79,000USD | 140,000USD | -78,000USD |
| Common Stock Shares Outstanding | 147,615,197shares | 120,187,689shares | 105,815,038shares | 102,372,820shares | 101,943,000shares | 101,055,000shares | 94,372,000shares | 87,766,000shares |
| Non Current Assets Total | 80,757,000USD | 83,118,000USD | 85,508,000USD | 75,588,000USD | 76,189,000USD | 76,635,000USD | 70,022,000USD | 71,373,000USD |
| Non Current Liabilities Total | 284,831,000USD | 283,441,000USD | 313,260,000USD | 291,504,000USD | 35,417,000USD | 37,445,000USD | 42,223,000USD | 42,694,000USD |
| Non Current Liabilities Other | 4,556,000USD | 4,583,000USD | 4,596,000USD | 4,637,000USD | 4,613,000USD | 4,663,000USD | 4,591,000USD | 4,321,000USD |
| Non Currrent Assets Other | 45,711,000USD | 47,364,000USD | 2,996,000USD | 2,963,000USD | 3,177,000USD | 3,134,000USD | 3,048,000USD | 3,015,000USD |
| Net Working Capital | 333,574,000USD | 252,395,000USD | 210,592,000USD | 350,503,000USD | 218,723,000USD | 384,246,000USD | 288,206,000USD | 355,061,000USD |
| Unclassified Non Current Liabilities | 38,363,000USD | 39,958,000USD | 40,394,000USD | 29,797,000USD | 30,804,000USD | 32,782,000USD | 37,632,000USD | 38,373,000USD |
| Unclassified Equity | -1,929,550,000USD | -1,740,292,000USD | -1,565,695,000USD | -1,586,090,000USD | -1,551,879,000USD | -1,544,333,000USD | -1,288,661,000USD | -1,214,721,000USD |
| Short Term Debt | — | — | 5,512,000USD | 4,696,000USD | 4,708,000USD | 3,802,000USD | 3,676,000USD | 3,550,000USD |
| Net Receivables | — | — | — | — | — | 2,597,000USD | 5,318,000USD | 7,522,000USD |
| Other Assets | — | — | — | — | — | — | 1,000USD | 1USD |
| Inventory | — | — | — | — | — | — | -5,318,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 451,447,000USD | 615,107,000USD | 513,212,000USD | 661,783,000USD | 142,061,000USD | 111,499,000USD | 344,264,000USD | 290,012,000USD |
| Intangible Assets | 18,400,000USD | 18,400,000USD | 18,400,000USD | 18,400,000USD | 18,400,000USD | 39,087,000USD | — | — |
| Other Current Assets | 49,192,000USD | 49,884,000USD | 47,375,000USD | 75,488,000USD | 2,121,000USD | 10,000USD | 11,554,000USD | 8,090,000USD |
| Total Liab | 399,375,000USD | 191,671,000USD | 85,237,000USD | 123,012,000USD | 47,370,000USD | 34,718,000USD | 351,688,000USD | 139,092,000USD |
| Total Stockholder Equity | 52,072,000USD | 423,436,000USD | 427,975,000USD | 538,771,000USD | 94,691,000USD | 76,781,000USD | -7,424,000USD | 150,920,000USD |
| Other Current Liab | 104,291,000USD | 132,395,000USD | 36,538,000USD | 76,299,000USD | 37,160,000USD | 27,119,000USD | 52,102,000USD | 8,782,000USD |
| Common Stock | 1,934,276,000USD | 1,656,702,000USD | 887,528,000USD | 615,742,000USD | 1,676,792,000USD | 1,249,547,000USD | 881,426,000USD | 554,384,000USD |
| Capital Stock | 1,934,276,000USD | 1,656,702,000USD | 887,528,000USD | 615,742,000USD | 0USD | — | — | — |
| Retained Earnings | -2,084,536,000USD | -1,345,714,000USD | -499,292,000USD | -91,124,000USD | -2,585,755,000USD | -1,739,169,000USD | -972,373,000USD | -443,568,000USD |
| Good Will | 1,390,000USD | 1,390,000USD | 1,390,000USD | 1,390,000USD | 1,390,000USD | 0USD | — | — |
| Cash | 229,957,000USD | 99,134,000USD | 248,402,000USD | 204,877,000USD | 76,057,000USD | 82,506,000USD | 316,727,000USD | 264,249,000USD |
| Cash And Short Term Investments | 319,137,000USD | 485,991,000USD | 381,819,000USD | 465,341,000USD | 76,057,000USD | 82,506,000USD | 316,727,000USD | 264,249,000USD |
| Total Current Assets | 368,329,000USD | 538,472,000USD | 442,446,000USD | 586,968,000USD | 94,823,000USD | 89,756,000USD | 328,281,000USD | 272,339,000USD |
| Total Current Liabilities | 115,934,000USD | 154,226,000USD | 55,423,000USD | 90,021,000USD | 41,935,000USD | 29,877,000USD | 66,173,000USD | 19,534,000USD |
| Net Debt | 48,901,000USD | -62,550,000USD | -217,525,000USD | -171,277,000USD | 550,663,000USD | 184,952,000USD | -316,727,000USD | -146,734,000USD |
| Short Long Term Debt Total | 278,858,000USD | 36,584,000USD | 30,877,000USD | 33,600,000USD | 627,159,000USD | 267,458,000USD | — | 117,515,000USD |
| Long Term Debt | 238,900,000USD | — | — | — | 626,720,000USD | — | — | — |
| Short Term Investments | 89,180,000USD | 386,857,000USD | 133,417,000USD | 260,464,000USD | 192,648,000USD | 223,185,000USD | — | — |
| Accounts Payable | 11,643,000USD | 18,029,000USD | 15,577,000USD | 10,703,000USD | 4,775,000USD | 2,758,000USD | 14,071,000USD | 10,752,000USD |
| Property Plant Equipment Net | 15,964,000USD | 53,711,000USD | 48,576,000USD | 52,440,000USD | 18,232,000USD | 13,560,000USD | 8,152,000USD | 6,248,000USD |
| Property Plant Equipment Gross | 77,148,000USD | 65,917,000USD | 56,859,000USD | 57,354,000USD | 21,574,000USD | 15,265,000USD | — | — |
| Accumulated Other Comprehensive Income | 8,348,000USD | 79,000USD | -65,000USD | 284,000USD | -73,000USD | 314,000USD | — | — |
| Common Stock Shares Outstanding | 107,624,885shares | 91,234,000shares | 71,201,000shares | 44,741,000shares | 39,375,944shares | 39,375,944shares | 48,490,000shares | 48,489,890shares |
| Non Current Assets Total | 83,118,000USD | 76,635,000USD | 70,766,000USD | 74,815,000USD | 47,238,000USD | 21,743,000USD | 15,983,000USD | 17,673,000USD |
| Non Current Liabilities Total | 283,441,000USD | 37,445,000USD | 29,814,000USD | 32,991,000USD | 5,435,000USD | 4,841,000USD | 285,515,000USD | 119,558,000USD |
| Non Current Liabilities Other | 4,583,000USD | 4,663,000USD | 2,245,000USD | 2,410,000USD | 586,189,000USD | 4,841,000USD | — | — |
| Non Currrent Assets Other | 47,364,000USD | 3,134,000USD | 2,400,000USD | 2,585,000USD | 3,216,000USD | 1,007,000USD | 7,831,000USD | 11,425,000USD |
| Net Working Capital | 252,395,000USD | 384,246,000USD | 387,023,000USD | 496,947,000USD | 52,888,000USD | 59,879,000USD | — | — |
| Unclassified Non Current Liabilities | 39,958,000USD | 32,782,000USD | 27,569,000USD | 28,171,000USD | -1,223,222,000USD | -1,912,000USD | 285,515,000USD | 119,558,000USD |
| Unclassified Equity | -1,740,292,000USD | -1,544,333,000USD | -847,724,000USD | -601,873,000USD | 1,003,727,000USD | 566,089,000USD | 83,523,000USD | 40,104,000USD |
| Short Term Debt | — | 3,802,000USD | 3,308,000USD | 3,019,000USD | 439,000USD | 675,000USD | — | — |
| Net Receivables | — | 2,597,000USD | 13,252,000USD | 46,139,000USD | 9,911,000USD | 120,111,000USD | — | — |
| Other Assets | — | — | 1USD | 2,585,000USD | 3,216,000USD | 1,007,000USD | — | — |
| Inventory | — | — | -396,000USD | 56,157,000USD | 6,734,000USD | 39,563,000USD | — | — |
| Other Liab | — | — | — | 2,410,000USD | 2,638,000USD | 1,912,000USD | — | — |
| Current Deferred Revenue | — | — | — | -38,231,000USD | -439,000USD | -675,000USD | — | — |
| Long Term Investments | — | — | — | 0USD | 6,000,000USD | 7,176,000USD | — | — |
| Net Tangible Assets | — | — | — | 518,685,000USD | -735,818,000USD | 16,781,000USD | — | — |
| Unclassified Current Assets | — | — | — | -56,157,000USD | -192,648,000USD | -375,619,000USD | — | — |
| Unclassified Non Current Assets | — | — | — | -2,585,000USD | -3,216,000USD | -40,094,000USD | — | — |
| Deferred Long Term Liab | — | — | — | — | 13,110,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -130,532,000USD | -145,555,000USD | -173,443,000USD | -198,147,000USD | -221,677,000USD | -186,843,000USD | -160,304,000USD | -319,771,000USD |
| Depreciation | 2,366,000USD | 2,573,000USD | 3,125,000USD | 1,978,000USD | 2,246,000USD | 2,461,000USD | 1,994,000USD | 977,000USD |
| Stock Based Compensation | 28,286,000USD | 16,952,000USD | 21,535,000USD | 20,812,000USD | 53,062,000USD | 12,694,000USD | 12,160,000USD | 12,232,000USD |
| Other Non Cash Items | 3,033,000USD | 5,193,000USD | 6,078,000USD | -11,137,000USD | 5,610,000USD | 6,961,000USD | -15,643,000USD | 174,305,000USD |
| Change In Working Capital | -53,071,000USD | -9,825,000USD | -3,011,000USD | 18,558,000USD | -4,365,000USD | -6,015,000USD | 20,517,000USD | -23,309,000USD |
| Total Cash From Operating Activities | -149,918,000USD | -130,662,000USD | -145,716,000USD | -167,936,000USD | -165,124,000USD | -170,742,000USD | -141,276,000USD | -167,798,000USD |
| Capital Expenditures | 0USD | -8,000USD | -13,000USD | -233,000USD | -461,000USD | -49,000USD | -611,000USD | -2,949,000USD |
| Free Cash Flow | -149,918,000USD | -130,670,000USD | -145,729,000USD | -168,169,000USD | -165,585,000USD | -170,791,000USD | -141,887,000USD | -170,747,000USD |
| Investments | 15,212,000USD | -13,731,000USD | 164,967,000USD | -15,546,000USD | 164,879,000USD | -87,676,000USD | -93,398,000USD | -97,931,000USD |
| Total Cashflows From Investing Activities | 15,212,000USD | -13,739,000USD | 164,967,000USD | -15,546,000USD | 164,879,000USD | -87,676,000USD | -93,398,000USD | -97,931,000USD |
| Total Cash From Financing Activities | 179,016,000USD | 188,796,000USD | 122,000USD | 249,830,000USD | 369,000USD | 272,853,000USD | 80,375,000USD | 321,123,000USD |
| Issuance Of Capital Stock | 178,884,000USD | 189,175,000USD | 0USD | 0USD | 0USD | 271,284,000USD | 76,361,000USD | — |
| Change In Cash | 44,326,000USD | 44,395,000USD | 19,387,000USD | 66,308,000USD | 147,000USD | 14,523,000USD | -154,299,000USD | 54,797,000USD |
| Begin Period Cash Flow | 232,779,000USD | 188,384,000USD | 168,997,000USD | 102,689,000USD | 102,542,000USD | 88,019,000USD | 242,318,000USD | 184,506,000USD |
| End Period Cash Flow | 277,105,000USD | 232,779,000USD | 188,384,000USD | 168,997,000USD | 102,689,000USD | 102,542,000USD | 88,019,000USD | 239,303,000USD |
| Other Cashflows From Financing Activities | 179,016,000USD | -194,000USD | 122,000USD | 249,830,000USD | 369,000USD | 1,569,000USD | 4,014,000USD | 238,000USD |
| Unclassified Financing Cash Flow | -178,884,000USD | 187,157,000USD | — | — | — | 259,783,000USD | — | 320,885,000USD |
| Net Borrowings | — | 0USD | 0USD | — | — | — | 0USD | — |
| Sale Purchase Of Stock | — | 1,833,000USD | — | — | — | 11,501,000USD | — | — |
| Other Cashflows From Investing Activities | — | — | -20,000USD | -1,829,000USD | — | — | 391,000USD | — |
| Unclassified Investing Cash Flow | — | — | — | 2,062,000USD | — | — | — | 2,949,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | — | -12,232,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -738,822,000USD | -846,422,000USD | -408,168,000USD | -570,279,000USD | -213,796,000USD | -118,668,000USD | -528,805,000USD | -240,922,000USD |
| Depreciation | 9,922,000USD | 7,855,000USD | 6,912,000USD | 1,386,000USD | 1,393,000USD | 72,000USD | — | — |
| Stock Based Compensation | 112,361,000USD | 71,963,000USD | 28,787,000USD | 193,556,000USD | 65,639,000USD | 29,500,000USD | 54,972,000USD | 16,925,000USD |
| Other Non Cash Items | 5,744,000USD | 167,340,000USD | 16,131,000USD | 106,252,000USD | -740,000USD | 4,162,000USD | 93,183,000USD | 21,466,000USD |
| Change In Working Capital | 1,357,000USD | 16,811,000USD | 24,613,000USD | -28,604,000USD | 1,664,000USD | 8,977,000USD | 3,319,000USD | 5,390,000USD |
| Total Cash From Operating Activities | -609,438,000USD | -582,453,000USD | -331,725,000USD | -297,689,000USD | -145,840,000USD | -75,957,000USD | -377,331,000USD | -197,141,000USD |
| Capital Expenditures | -715,000USD | -4,049,000USD | -3,048,000USD | -41,074,000USD | -938,000USD | -2,697,000USD | -2,534,000USD | -4,165,000USD |
| Free Cash Flow | -610,153,000USD | -586,502,000USD | -334,773,000USD | -338,763,000USD | -146,778,000USD | -78,654,000USD | -379,865,000USD | -201,306,000USD |
| Investments | 303,125,000USD | -244,974,000USD | 129,830,000USD | -304,790,000USD | 28,270,000USD | -2,697,000USD | — | — |
| Total Cashflows From Investing Activities | 300,561,000USD | -244,974,000USD | 129,830,000USD | -304,790,000USD | 944,000USD | -2,697,000USD | -3,784,000USD | -10,540,000USD |
| Net Borrowings | 250,000,000USD | 0USD | 0USD | — | 420,441,000USD | — | — | — |
| Total Cash From Financing Activities | 439,117,000USD | 677,774,000USD | 211,908,000USD | 767,597,000USD | 138,447,000USD | 152,242,000USD | 434,593,000USD | 340,462,000USD |
| Sale Purchase Of Stock | 1,833,000USD | 11,501,000USD | — | — | 345,626,000USD | — | — | — |
| Issuance Of Capital Stock | 189,175,000USD | 666,165,000USD | 243,225,000USD | 283,804,000USD | 0USD | 0USD | — | — |
| Change In Cash | 130,237,000USD | -149,578,000USD | 9,516,000USD | 165,547,000USD | -6,449,000USD | 73,588,000USD | 53,478,000USD | 132,781,000USD |
| Begin Period Cash Flow | 102,542,000USD | 252,120,000USD | 242,604,000USD | 77,057,000USD | 83,506,000USD | 9,918,000USD | 264,249,000USD | 131,468,000USD |
| End Period Cash Flow | 232,779,000USD | 102,542,000USD | 252,120,000USD | 242,604,000USD | 77,057,000USD | 83,506,000USD | 317,727,000USD | 264,249,000USD |
| Other Cashflows From Investing Activities | -1,849,000USD | 391,000USD | — | -4,000,000USD | -28,270,000USD | -43,100,000USD | -1,250,000USD | — |
| Other Cashflows From Financing Activities | -194,000USD | 2,258,000USD | -31,317,000USD | 34,663,000USD | 138,447,000USD | 152,242,000USD | 434,593,000USD | 340,462,000USD |
| Unclassified Financing Cash Flow | 187,478,000USD | 664,015,000USD | — | 449,130,000USD | -766,067,000USD | — | — | — |
| Unclassified Investing Cash Flow | — | 3,658,000USD | 3,048,000USD | 45,074,000USD | 1,882,000USD | 45,797,000USD | — | -6,375,000USD |
| Change To Liabilities | — | — | — | 5,928,000USD | 117,202,000USD | 222,000USD | — | — |
| Change To Account Receivables | — | — | — | — | -188,158,000USD | -120,111,000USD | — | — |
| Change To Inventory | — | — | — | — | -24,102,000USD | -37,965,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | — | 40,301,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2022Quarterly · 2022-06-30 | Product | Collaboration And Other | 21,125,000 | USD | 0001689813-22-000064 |
| Q2 2022Quarterly · 2022-06-30 | Product | Product | 193,954,000 | USD | 0001689813-22-000064 |
| Q1 2022Quarterly · 2022-03-31 | Product | Collaboration And Other | 195,262,000 | USD | 0001689813-22-000041 |
| Q1 2022Quarterly · 2022-03-31 | Product | Product | 123,590,000 | USD | 0001689813-22-000041 |
| Q2 2021Quarterly · 2021-06-30 | Product | Collaboration And Other | 0 | USD | 0001689813-22-000064 |
| Q2 2021Quarterly · 2021-06-30 | Product | Product | 92,933,000 | USD | 0001689813-22-000064 |
| Q1 2021Quarterly · 2021-03-31 | Product | Collaboration And Other | 0 | USD | 0001689813-22-000041 |
| Q1 2021Quarterly · 2021-03-31 | Product | Product | 43,823,000 | USD | 0001689813-22-000041 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.